Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001013762-24-000516
Filing Date
2024-07-22
Accepted
2024-07-22 17:00:34
Documents
9

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0209789-f1_purplebio.htm F-1 341982
2 OPINION OF FISCHER (FBC & CO.) ea020978901ex5-1_purplebio.htm EX-5.1 10440
3 OPINION OF HAYNES AND BOONE, LLP, U.S. LEGAL COUNSEL TO THE REGISTRANT ea020978901ex5-2_purplebio.htm EX-5.2 11773
4 CONSENT OF SOMEKH CHAIKIN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, A MEMB ea020978901ex23-3_purplebio.htm EX-23.3 2026
5 FILING FEE TABLE ea020978901ex-fee_purplebio.htm EX-FILING FEES 38980
6 GRAPHIC image_001.jpg GRAPHIC 2536
7 GRAPHIC ex5-1_001.jpg GRAPHIC 24136
8 GRAPHIC ex5-2_001.jpg GRAPHIC 2903
9 GRAPHIC ex5-2_002.jpg GRAPHIC 1358
  Complete submission text file 0001013762-24-000516.txt   449611
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-280947 | Film No.: 241132146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)